(NYSE:FCX), LOS ANGELES, Dec. 01, 2025 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP reminds investors of the upcoming January 12, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Freeport-McMoran Inc. (“Freeport” or the “Company”) (NYSE: FCX) securities between February 15, […]

(NYSE:BAX), LOS ANGELES, Dec. 01, 2025 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP reminds investors of the upcoming December 15, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Baxter International, Inc. (“Baxter” or the “Company”) (NYSE: BAX) common stock between

(NYSE:FUN),(NASDAQ:TLX),(NYSE:LRN),(NYSE:PRMB), BENSALEM, Pa., Dec. 01, 2025 (GLOBE NEWSWIRE) — Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. Investors suffering losses on their investments are encouraged to

(ASX – Trade24:360.AX),(NASDAQ:LIF), SAN FRANCISCO, Dec. 01, 2025 (GLOBE NEWSWIRE) — Life360 (Nasdaq: LIF; ASX: 360), the leading family connection and safety company, today announced the appointment of Matt Cullen as General Counsel, effective December 1, 2025. Cullen joins the company's leadership team, reporting directly to Chief Executive Officer Lauren Antonoff. Cullen will lead the

(NASDAQ:SNPS), NEW YORK, Dec. 01, 2025 (GLOBE NEWSWIRE) — Attorney Advertising–Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Synopsys, Inc. (“Synopsys” or “the Company”) (NASDAQ: SNPS) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for

National Advertising Division Will Refer Rascals to the Federal Trade Commission for Failure to Comply with Compliance Inquiry Recommendation Following a compliance review stemming from a prior decision (Case #7376) and concerns submitted by The Procter & Gamble Company (P&G), BBB National Programs' National Advertising Division will refer Rascals International Limited to the Federal Trade

INSP INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Inspire Medical Systems, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit GlobeNewswire December 01, 2025 NEW YORK, Dec. 01, 2025 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class

TLX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Telix Pharmaceuticals Limited Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit GlobeNewswire December 01, 2025 NEW YORK, Dec. 01, 2025 (GLOBE NEWSWIRE) — Attorney Advertising–Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has

JHX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that James Hardie Industries plc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit GlobeNewswire December 01, 2025 NEW YORK, Dec. 01, 2025 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class

Longeveron New MRI Biomarker Data Linking Neuroinflammation to Clinical Outcomes in Patients with Mild Alzheimer's Disease Presented at the Clinical Trials on Alzheimer's Disease Conference (CTAD 2025) GlobeNewswire December 01, 2025 Results obtained in the Phase 2 placebo-controlled CLEAR-MIND clinical trial showed that treatment with stem cell therapy laromestrocel was associated with a reduction in